Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux [clinicaltrials:NCT00378027]
Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux [clinicaltrials:NCT00378027]
Bio2RDF identifier
NCT00378027
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00378027
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
To assess the safety an ...... ute pulmonary
embolism.
brief title [clinicaltrials_vocabulary:brief-title]
Arixtra PE Study- Outpatient M ...... aily Subcutaneous Fondaparinux
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2008-11-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
The current standard th ...... of acute pulmonary embolism.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2006-09-18T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Anticoagulation
Outpatient
Pulmonary Embolism
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2008-05-20T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00378027
official title [clinicaltrials_vocabulary:official-title]
Phase IV, Single Arm Study to ...... nt of Acute Pulmonary Embolism
org study id [clinicaltrials_vocabulary:org-study-id]
Arixtra PE Study 05-202
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2006-10-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2008-05-01T00:00:00Z
why stopped [clinicaltrials_vocabulary:why-stopped]
enrollment criteria not met by PI patient population
identifier
clinicaltrials:NCT00378027
title
Arixtra PE Study- Outpatient M ...... aily Subcutaneous Fondaparinux
@en
type
label
Arixtra PE Study- Outpatient M ...... x [clinicaltrials:NCT00378027]
@en